Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 12;12(11):ofaf688.
doi: 10.1093/ofid/ofaf688. eCollection 2025 Nov.

Performance of Diagnostic Tests for Histoplasmosis Across Clinical Syndromes and Immune Statuses

Nicolas Barros  1   2 , Mitch McClean  1 , Elisa Sarmiento  1 , Shanna Noveroske  2 , John Witt  2 , L Joseph Wheat  2
Affiliations

Performance of Diagnostic Tests for Histoplasmosis Across Clinical Syndromes and Immune Statuses

Nicolas Barros et al. Open Forum Infect Dis. .

Abstract

Background: Histoplasmosis, caused by Histoplasma capsulatum, presents with a broad clinical spectrum from asymptomatic infection to disseminated disease (DH). Diagnostic modalities, culture, histopathology, antigen detection, and serologic testing, vary in performance. We evaluated their sensitivity and specificity across clinical presentations and immune statuses.

Methods: We conducted a retrospective diagnostic study of adults evaluated at Indiana University Health Medical Center who had serum and/or urine submitted for Histoplasma antigen testing to Miravista Diagnostics. Clinical classification (proven, probable) was based on laboratory, imaging, and clinical data according to EORTC/MSG criteria. Controls were patients tested for histoplasmosis but found to have an alternative diagnosis. Diagnostic methods included antigen enzyme immunoassay (EIA), antibody EIA (IgG/IgM), immunodiffusion (ID), complement fixation (CF), and fungal cultures.

Results: Among 205 patients, 125 were classified as histoplasmosis (54 proven, 71 probable) and 80 as controls. Antigen EIA in serum and/or urine had sensitivity 121/124 (97.6%) and specificity 75/80 (93.7%). IgG/IgM antibody EIA detected 89/111 (80.2%) cases with specificity 73/79 (92.4%) at a 20 EU/mL cutoff. Combining antigen and antibody testing increased sensitivity to 109/110 (99.1%). Among 75 patients with both serum and urine antigen tested, combined testing added 3/75 (4%) cases beyond urine alone. Antibody sensitivity declined in immunocompromised patients (75.0% vs 93.3% in immunocompetent, P = .0134), while antigen sensitivity remained high across groups.

Conclusions: Histoplasma antigen testing is the most sensitive diagnostic method. Antibody testing complements antigen in selected populations, particularly immunocompetent patients with pulmonary disease. Culture remains a complementary but less sensitive tool.

Keywords: antibody; antigen; diagnosis; histoplasma; histoplasmosis.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. N. B., S. N., J. W., and L. J. W. work at Miravista Diagnostics. M. M. and E. S. have no conflicts of interest to disclose. All other authors report no potential conflicts.

Figures

Figure 1.
Figure 1.
Antigen concentration by disease severity and immune status. A, Serum antigen concentrations by EIA. B, Urine antigen concentrations by EIA.
See this image and copyright information in PMC

References

    1. Eichenberger EM, Little JS, Baddley JW. Histoplasmosis. Infect Dis Clin North Am 2025; 39:145–61. - PMC - PubMed
    1. Barros N, Wheat JL, Hage C. Pulmonary histoplasmosis: a clinical update. J Fungi (Basel) 2023; 9:236. - PMC - PubMed
    1. Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol 2017; 55:1612–20. - PMC - PubMed
    1. Richer SM, Smedema ML, Durkin MM, et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis 2016; 62:896–902. - PMC - PubMed
    1. Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14:1587–91. - PMC - PubMed